KBLB — Kraig Biocraft Laboratories Share Price
0.000.00%
Last trade - 00:00- $93.84m
- $100.02m
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | n/a | ||
| Price to Tang. Book | n/a | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | n/a | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | n/a | ||
| Return on Equity | n/a | ||
| Operating Margin | n/a | ||
Financial Summary
| Year End 31st Dec | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $m | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Kraig Biocraft Laboratories, Inc. develops fibers using recombinant deoxyribonucleic acid (DNA) technology for commercial applications in technical textiles. The Company uses genetically engineered silkworms that produce spider silk proteins to create its recombinant spider silk. Its primary fiber technology includes natural and engineered variants of spider silk produced from domesticated mulberry silkworms. The Company’s products use the characteristics of spider silk, specifically dragline silk from Nephila clavipes and variants thereof. Its recombinant spider silk fiber blends the silk proteins found in spider silk with the native silkworm silk proteins. Its products include Monster Silk, Dragon Silk, and other products. Its applications include performance apparel, workwear, filtration, luxury fashion, flexible composites, medical implants, cosmetics and more. The Company also focuses on developing various recombinant silks and other protein-based fibers and materials.
Directors
- Last Annual
- December 31st, 2024
- Last Interim
- December 31st, 2024
- Incorporated
- April 25th, 2006
- Public Since
- February 29th, 2008
- No. of Shareholders
- 33
- No. of Employees
- 7
- Sector
- Chemicals
- Industry
- Basic Materials
- Exchange
- Pink Sheets on Nasdaq
- Shares in Issue
- 1,042,646,733
- Address
- 2723 South State Street, Suite 150, ANN ARBOR, 48104
- Web
- https://www.kraiglabs.com/
- Phone
- +1 7346198066
- Auditors
- M&K CPAS, PLLC
Upcoming Events for KBLB
Q2 2025 Kraig Biocraft Laboratories Inc Earnings Release
Similar to KBLB
Advanced Container Technologies
Pink Sheets on Nasdaq
Alkane
Pink Sheets on Nasdaq
Angstrom Technologies
Pink Sheets on Nasdaq
Asia Carbon Industries
Pink Sheets on Nasdaq
BioLargo
Pink Sheets on Nasdaq
FAQ
What is the Kraig Biocraft Laboratories share price?
As of Today at 21:38 UTC, shares in Kraig Biocraft Laboratories are trading at $0.09. This share price information is delayed by 15 minutes.
How has the Kraig Biocraft Laboratories share price performed this year?
Shares in Kraig Biocraft Laboratories last closed at $0.09 and the price had moved by +5.39% over the past 365 days. In terms of relative price strength the Kraig Biocraft Laboratories share price has underperformed the S&P500 Index by -0.42% over the past year.
What are the analyst and broker recommendations for Kraig Biocraft Laboratories?
There is no consensus recommendation for this security.
Find out moreWhat is the Kraig Biocraft Laboratories dividend yield?
Kraig Biocraft Laboratories does not currently pay a dividend.
Does Kraig Biocraft Laboratories pay a dividend?
Kraig Biocraft Laboratories does not currently pay a dividend.
When does Kraig Biocraft Laboratories next pay dividends?
Kraig Biocraft Laboratories does not currently pay a dividend.
How do I buy Kraig Biocraft Laboratories shares?
To buy shares in Kraig Biocraft Laboratories you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Kraig Biocraft Laboratories?
As of the previous close price of $0.09, shares in Kraig Biocraft Laboratories had a market capitalisation of $93.84m.
Where are Kraig Biocraft Laboratories shares listed?
Here are the trading details for Kraig Biocraft Laboratories:
- Country of listing: United States
- Exchange: PNK
- Ticker Symbol: KBLB
What kind of share is Kraig Biocraft Laboratories?
Based on an overall assessment of its quality, value and momentum Kraig Biocraft Laboratories is currently classified as a Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Kraig Biocraft Laboratories share price forecast for 2025?
We could not find analyst target price data for this security.
Find out moreWhat is the trend in the Kraig Biocraft Laboratories share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Kraig Biocraft Laboratories. Over the past six months, its share price has outperformed the S&P500 Index by +8.87%.
As of the last closing price of $0.09, shares in Kraig Biocraft Laboratories were trading -5.82% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Kraig Biocraft Laboratories PE Ratio?
The Kraig Biocraft Laboratories PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at $0.09.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Kraig Biocraft Laboratories?
Kraig Biocraft Laboratories' management team is headed by:
- Kim Thompson - PRE
- Kenneth Le - CEX
- Jonathan Rice - COO